Umb Bank, N.A. Takeda Pharmaceutical CO LTD Transaction History
Umb Bank, N.A.
- $6.22 Billion
- Q4 2024
A detailed history of Umb Bank, N.A. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Umb Bank, N.A. holds 350 shares of TAK stock, worth $5,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350
Previous 226
54.87%
Holding current value
$5,026
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$189 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$80.4 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$66.5 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$60.5 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$46.5 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...